Description:
Levosalbutamol + Ipratropium is a combination respiratory medication used in the treatment of chronic obstructive pulmonary disease (COPD) and asthma. It contains Levosalbutamol, a short-acting bronchodilator, and Ipratropium, an anticholinergic agent. Together, they help relax the airway muscles, reduce mucus production, and improve airflow, providing fast and effective relief from symptoms such as wheezing, breathlessness, and chest tightness.
Therapeutic Uses:
Management of COPD, including chronic bronchitis and emphysema
Treatment of acute exacerbations of asthma
Symptomatic relief from bronchospasm in obstructive airway diseases
Mechanism of Action:
Levosalbutamol stimulates beta-2 adrenergic receptors in the bronchial smooth muscle, causing bronchodilation and rapid relief from airway constriction.
Ipratropium works by blocking muscarinic receptors, thereby reducing cholinergic-mediated bronchoconstriction and airway secretions.
Dosage Form:
Nebuliser solution or metered-dose inhaler (depending on formulation)
Prescription Status:
Prescription-only medication
Note:
This medication provides short-term relief and should be used as prescribed by a healthcare professional. It is particularly effective when administered via nebulisation during acute episodes. Proper inhalation technique and regular monitoring are essential for optimal therapeutic benefit.
Would you like this formatted for inclusion in a product catalog or e-commerce listing?
